TABLE 3.

Patient serum IgG reactivities to VlsE-derived peptides

Peptide	% of serum samples with IgG reactivity
	Early localized diseasea	Disseminated diseaseb	Total
Ct	17	64	35
N1	17	21	19
N2	4	57	24
N3	9	21	14
C2	13	7	11
C4	4	14	8
C6	65	100	78
VlsE	13	79	38

^aPatients NA18, NA19, NA21, and NA23 to NA42.

^bPatients NA6 to NA17, NA20, and NA22.